RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

NCT03445650 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Sjogren-Larsson Syndrome

Interventions

DRUG: ADX-102 1% Topical Dermal Cream (reproxalap)
DRUG: Vehicle of ADX-102 Topical Dermal Cream

Sponsor

Aldeyra Therapeutics, Inc.